本页面由Tiger Trade Technology Pte. Ltd.提供服务

Recursion Pharmaceuticals, Inc.

4.01
-0.3500-8.03%
盘后:4.00-0.0100-0.25%19:59 EDT
成交量:2,378.53万
成交额:9,669.24万
市值:21.45亿
市盈率:-3.92
高:4.37
开:4.31
低:3.91
收:4.36
52周最高:7.18
52周最低:2.77
股本:5.35亿
流通股本:5.22亿
量比:0.48
换手率:4.55%
股息:- -
股息率:- -
每股收益(TTM):-1.0219
每股收益(LYR):-1.4410
净资产收益率:-56.58%
总资产收益率:-27.33%
市净率:2.34
市盈率(LYR):-2.78

数据加载中...

2024/12/11

关联方拟减持公告

Form 144 | RECURSION PHARMACEUTICALS高管Michael Secora拟减持15000股,总价约11.22万美元
2024/12/10

关联方拟减持公告

Form 144 | Recursion Pharmaceuticals 高管 Michael Secora 拟减持15000股,总价约11.63万美元
2024/12/05

关联方拟减持公告

Form 144 | Recursion Pharmaceuticals高管Gibson Christopher拟减持20,000股,总价约14.24万美元
2024/12/04

关联方拟减持公告

Form 144 | RECURSION PHARMACEUTICALS, INC. 高管 Gibson Christopher 拟减持20000股,总价约14.32万美元
2024/12/03

重要事件披露

Form 8-K - Current report
2024/11/27

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/11/26

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/20

重要事件披露

Form 8-K - Current report
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report